Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad, Myriad RBM Partner on Biomarker Kits

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories and Myriad RBM said after the close of the market on Tuesday they are partnering to develop and distribute immunoassays kits.

Myriad RBM, a subsidiary of Myriad Genetics formed when it acquired Rules-Based Medicine last year, is granting Bio-Rad exclusive distribution rights, for research purposes, to it catalog of quantitative multiplexed immunoassays to run on Bio-Rad's Bio-Plex 200, Bio-Plex 3D, and Bio-Plex MagPix instruments.

Myriad RBM's assay provide for multiplex testing of samples with very low volumes for the studies focused on toxicology, oncology, immunology, and cardiovascular and other diseases.

"This agreement combines Myriad RBM's industry-leading menu of multiplexed immunoassays with Bio-Rad's unrivaled global commercial distribution capabilities," Craig Benson, President of Myriad RBM, said in a statement. "Our partnership with Bio-Rad will help researchers and clinicians on the front lines of medicine to develop biomarker profiles that may predict, detect, or monitor disease progression in an effort to optimize treatment and improve patient care."

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.